发明申请
US20120184741A1 SOLID FORMS OF GYRASE INHIBITOR (R)-1-ETHYL-3-[5-[2-(1-HYDROXY-METHYL-ETHYL)PYRIMIDIN-5-YL]-7-(TETRAHYDROFURAN-2-YL)-1H-BENZIMIDAZOL-2-YL]UREA
有权
γ-乙基-3- [5- [2-(1-羟基 - 甲基)乙基]嘧啶-5-基] -7-(四氢呋喃-2-基)-1H-苯并咪唑的固体形式 -2-YL]尿素
- 专利标题: SOLID FORMS OF GYRASE INHIBITOR (R)-1-ETHYL-3-[5-[2-(1-HYDROXY-METHYL-ETHYL)PYRIMIDIN-5-YL]-7-(TETRAHYDROFURAN-2-YL)-1H-BENZIMIDAZOL-2-YL]UREA
- 专利标题(中): γ-乙基-3- [5- [2-(1-羟基 - 甲基)乙基]嘧啶-5-基] -7-(四氢呋喃-2-基)-1H-苯并咪唑的固体形式 -2-YL]尿素
-
申请号: US13349845申请日: 2012-01-13
-
公开(公告)号: US20120184741A1公开(公告)日: 2012-07-19
- 发明人: Dean Shannon , Brian Luisi , Yusheng Liao , Mariusz Krawiec
- 申请人: Dean Shannon , Brian Luisi , Yusheng Liao , Mariusz Krawiec
- 申请人地址: US MA Cambridge
- 专利权人: VERTEX PHARMACEUTICALS INCORPORATED
- 当前专利权人: VERTEX PHARMACEUTICALS INCORPORATED
- 当前专利权人地址: US MA Cambridge
- 主分类号: C07D405/14
- IPC分类号: C07D405/14
摘要:
The present application is directed to solid forms of compounds of formula (I): and pharmaceutically acceptable salts thereof, that inhibit bacterial gyrase and/or Topo IV and pharmaceutical compositions comprising said compounds and salts. These compounds and salts are useful in treating bacterial infection.
公开/授权文献
信息查询